Trending News
News
News
Target Set on Cancer Gene MCL1
Broad Institute and Dana-Farber colleagues identify several chemical compounds that tamp down the expression of the MCL1 gene.
News
e-Therapeutics’ Preliminary Results for the Year Ended 31 January 2012
Further drugs for infection and depression expected to enter trials in 2012.
News
Cytheris Appoints Damian Marron as Chief Executive Officer
Damian was previously CEO at Trophos SA.
News
Trophos Appoints Christine Placet as Chief Executive Officer
Christine becomes CEO under a succession plan designed to provide continuity for Trophos.
News
4SC AG Announces Election of Dr Thomas Werner to Chairman of the Supervisory Board
Company also elected Dr Manfred Rüdiger as its new deputy chairman.
News
Almac Introduces QP Facilitation Programme for Conducting Trials in the European Union
Programme vastly simplifies and expedites the QP release process.
News
Astex Earns $5.4 Million Milestone on Phase I Trial Initiation of a FGFR Kinase Inhibitor
Janssen has received approval to commence a Phase I study of FGFR kinase inhibitor.
News
Adocia Announces a Strengthened Intellectual Property on its Lead Project for its Chronic Wounds Treatment
USPTO and EPO have issued a patent to Adocia covering BioChaperone PDGF formulations for chronic wound treatment.
News
Oncolytics Announces Publication of Translational Clinical Trial Results in Science Translational Medicine
Cell carriage, delivery, and selective replication of an oncolytic virus in tumor in patients.
News
UBICHEM Group Adds New Large Scale Manufacturing Site
New manufacturing site expands UBICHEM Group’s presence in the non-pharma sector.
Advertisement